|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3466949 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18192207.1 |
| Europos patento paraiškos padavimo data | 2014-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-23 |
| (46) | Apibrėžties vertimo paskelbimo data | 2021-03-25 |
| (30) | Numeris | Data | Šalis |
| 201361920500 P | 2013-12-24 | US |
| (72) |
NORRIS, Derek J., US
DELUCCA, George V., US
GAVAI, Ashvinikumar V., US
QUESNELLE, Claude A., US
GILL, Patrice, US
O`MALLEY, Daniel, US
VACCARO, Wayne, US
LEE, Francis Y., US
DEBENEDETTO, Mikkel V., US
DEGNAN, Andrew P., US
FANG, Haiquan, US
HILL, Matthew D., US
HUANG, Hong, US
SCHMITZ, William D., US
STARRETT, JR, John E., US
HAN, Wen-Ching, US
TOKARSKI, John S., US
MANDAL, Sunil Kumar, IN
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Triciklinis junginys kaip priešvėžinis agentas |
| TRICYCLIC COMPOUND AS ANTICANCER AGENTS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2024-11-25 | 11 | 289.00 EUR |
| 2025-12-23 |